TAMPA, Fla. – The opportunity for people to invest in SynDaver Labs, a synthetic human manufacturer based in Tampa, is nearing the July 31 cutoff for their first private offering of common stock.
The company, which intends to go public in 2018, is seeking $1 million in financing through this initial round of private placement to fund expansion of their U.S. workforce.
One of their goals is to add new team members devoted to manufacturing, research and development, marketing and sales.
Funding will also go to creating SynDaver service centers in their largest overseas markets, which are currently China and Latin America.
The minimum investment to purchase common stock is $10,000. In addition to common stock, SynDaver also offers convertible debt and bonds as part of their capital structure.
SynDaver’s convertible debt has a 36-month term, pays two percent interest, and is offered in $5000 increments. Bonds are available with a 12-month term, paying four percent interest, and are offered in $1000 increments.
Over the last 4 years, SynDaver has achieved a 70 percent average annual growth rate and has doubled in size over the last year alone. They expect to double in size again this year, as well.
SynDaver also plans to expand their product offerings by developing newborn, preemie, and pediatric versions of the synthetic human product line. These models will enable surgical training in the neonatal and pediatric space in a way that is currently not possible without risking an actual human life.
“This year has been an exciting year at SynDaver,” said Dr. Christopher Sakezles, founder of SynDaver Labs. “Our growth is continuing at a tremendous pace and the publicity we’ve been able to garner has expanded our reach, adding new opportunities and new partnerships.”
One of those partnerships is with Tampa’s Museum of Science and Industry, which is expected to be formally announced later this month.
Investment in SynDaver labs is by invitation only. Those that wish to be considered for this private placement can submit a request on Syndaver’s website under “Investors”.
About SynDaver Labs
SynDaver Labs manufactures synthetic humans for training in schools, hospitals and military installations. SynDaver has the world’s largest database of live-tissue properties and all SynDaver tissues are made from water, salts, and fibers. The company currently has 10 patents on these materials, processes, and related products. SynDaver Labs is headquartered in Tampa, Florida and employs more than 100 people. The company also has an advanced research facility located in Phoenix, Arizona and is planning additional facilities in the U.S., China, Europe, and Latin America.